Sugammadex: Restricted vs Unrestricted or Selective vs Non-Selective?

Eissa S. , Lim K.S. Rocuronium and sugammadex as a novel management strategy in a patient with plasmacholinesterase deficiency presenting for electroconvulsive therapy. Anaesth Intensive Care 2011; 39: 764–765.

Visser W.A. , Ermens A.A.M. , de Boer H.D. , van Os E. Rocuronium reversed by sugammadex for electroconvulsive therapy in a patients with prolonged duration of action of succinyl-choline. Anaesth Intensive Care 2011; 39: 1153–1154.

Saeki N. , Kwon R. , Fukuda H. , Hamada H. , Kawamoto M. Electroconvulsive therapy using rocuronium and sugammadex in a patient with neurolept malignant syndrome. Anaesth Intensive Care 2011; 39: 762–763.

Porter M.V. , Paleologos M.S. The use of rocuronium in a patient with cystic fibrosis and end-stage lung disease made safe by sugammadex reversal. Anaesth Intensive Care 2011; 39: 299–302.

Baumgartner P. Rocuronium and sugammadex in myotonic dystrophy. Anaesth Intensive Care 2010; 38: 959–960.

Petrovski J. The use of sugammadex to reverse rocuronium in a patient with myotonic dystrophy. Anaesth Intensive Care 2011; 39: 505–506.

Desforges J.C.W. , McDonnell N.J. Sugammadex in the management of a failed intubation on a morbidly obese patient. Anaesth Intensive Care 2011; 39: 763–764.

McTernan C.N. , Rapeport D.A. , Ledowski T. Successful use of rocuronium and sugammadex in an anticipated difficult airway scenario. Anaesth Intensive Care 2010; 38: 390–392.

Yang L.P.H. , Keam S.J. Sugammadex: A review of its use in anaesthetic practice. Drugs 2009; 69: 919–942.

Suzuki T. , Kitajima O. , Ueda K. , Kondo Y. , Ogawa S. Reversibility of rocuronium-induced profound neuromuscular block with sugammadex in younger and older patients. Br J Anaesth 2011; 106: 823–826.

Illman H.L. , Laurila P. , Antila H. , Meretoja O.A. , Alahuhta S. , Olkkola K.T. The duration of residual block after administration of neostigmine or sugammadex at two visible twitches during train-of four monitoring. Anesth Analg 2011; 112: 63–68.

McDonagh D.L. , Benedict P.E. , Kovac A.L. , Drover D.R. , Brister N.W. , Morte J.B. Efficacy, safety, and pharmacokinetics of sugammadex for the reversal of rocuronium-induced neuromuscular blockade in elderly patients. Anesthesiology 2011; 114: 318–329.

White P.F. Facilitating recovery from anesthesia: assessing costs and benefits of anesthetic drugs. Anesth Analg 2010; 110: 273–275.

Fuchs-Buder T. , Meistelman C. , Schreiber J.U. Is sugammadex economically viable for routine use. Curr Opin Anaesthesiol 2012; 25: (in press).

Watts R.W. , London J.A. , van Wijk RMAW , Liu Y-L The influence of unrestricted use of sugammadex on clinical anaesthetic practice in a tertiary teaching hospital. Anaesth Intensive Care 2012; 40: 333–339.

Ledowski T. , Hillyard S. , Kozman A. , Johnston F. , Gillies E. , Greenaway M. Unrestricted access to sugammadex: impact on neuromuscular blocking agent choice, reversal practice, and associated healthcare costs. Anaesth Intensive Care 2012; 40: 340–343.

Kyle B.C. , Gaylard D. , Riley R.H. A persistent ‘can't intubate, can't oxygenate’ crisis despite rocuronium reversal with sugammadex. Anaesth Intensive Care 2012; 40: 344–346.

Bisschops M.M.A. , Holleman C. , Huitink J.M. Can sugammadex save a patient in a simulated “cannot intubate, cannot ventilate” situation? Anaesthesia 2010; 65: 936–941.

De Boer H.D. Neuromuscular transmission: new concepts and agents. J Crit Care 2009; 24: 36–42.

Menendez-Ozcoidi L. , Ortiz-Gomez J.R. , Olaguibei-Ribero J.M. , Salvador-Bravo M.J. Allergy to low dose sugammadex. Anaesthesia 2011; 66: 217–219.

Kovac A.L. Sugammadex: the first selective binding reversal agent for neuromuscular block. J Clin Anesth 2009; 21: 444–453.

Chow T.K.F. With the advent of sugammadex, a succinylcholine free anaesthetic in electroconvulsive therapy may be the future standard. Anaesth Intensive Care 2011; 39: 1154–1155.

McLoughlin P. Normal rocuronium sensitivity after titrated intraoperative sugammadex. Anaesth Intensive Care 2012; 40: 352.